Verici Dx Plc - ESG Rating & Company Profile powered by AI
Check the bottom of the webpage for potential risks for Verici Dx Plc based on industry, geography and marketcap. The ESG score includes 17 UN Sustainable Development Goals including: 'Quality Education', 'Decent Work & Economic Growth' and 'Life on Land'. Full Sustainability analysis of Verici Dx Plc are accessed by signing up for free.
Verici Dx Plc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.5; made up of an environmental score of 0.0, social score of 1.6 and governance score of 6.0.
2.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1481 | Tissue Regenix Group PLC | 2.6 | Medium |
| 1481 | Twist Bioscience Corp | 2.6 | Medium |
| 1499 | Verici Dx Plc | 2.5 | Medium |
| 1499 | Akeso Inc | 2.5 | Medium |
| 1499 | Allergan plc | 2.5 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Verici Dx Plc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Verici Dx Plc disclose current and historical energy intensity?
Sign up for free to unlockDoes Verici Dx Plc report the average age of the workforce?
Sign up for free to unlockDoes Verici Dx Plc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Verici Dx Plc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Verici Dx Plc disclose cybersecurity risks?
Sign up for free to unlockDoes Verici Dx Plc offer flexible work?
Sign up for free to unlockDoes Verici Dx Plc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Verici Dx Plc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Verici Dx Plc conduct supply chain audits?
Sign up for free to unlockDoes Verici Dx Plc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Verici Dx Plc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Verici Dx Plc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Verici Dx Plc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Verici Dx Plc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Verici Dx Plc disclose water use targets?
Sign up for free to unlockDoes Verici Dx Plc have careers partnerships with academic institutions?
Sign up for free to unlockDid Verici Dx Plc have a product recall in the last two years?
Sign up for free to unlockDoes Verici Dx Plc disclose incidents of discrimination?
Sign up for free to unlockDoes Verici Dx Plc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Verici Dx Plc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Verici Dx Plc disclose parental leave metrics?
Sign up for free to unlockDoes Verici Dx Plc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Verici Dx Plc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Verici Dx Plc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Verici Dx Plc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Verici Dx Plc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Verici Dx Plc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Verici Dx Plc involved in embryonic stem cell research?
Sign up for free to unlockDoes Verici Dx Plc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Verici Dx Plc disclose its waste policy?
Sign up for free to unlockDoes Verici Dx Plc report according to TCFD requirements?
Sign up for free to unlockDoes Verici Dx Plc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Verici Dx Plc disclose energy use targets?
Sign up for free to unlockDoes Verici Dx Plc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Verici Dx Plc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Verici Dx Plc
These potential risks are based on the size, segment and geographies of the company.
Verici Dx plc, an immuno-diagnostics development company, focuses on the kidney transplantation market. The company develops prognostic and diagnostic tests for kidney transplant patients. Its in-development tests include Clarava, a pre-transplant prognosis test for the risk of early acute rejection; Tuteva, a post-transplant test that focuses on acute cellular rejection; and Protega, a liquid biopsy that aims to predict the risk of fibrosis and long-term graft failure. The company was incorporated in 2020 and is based in Penarth, the United Kingdom.